ClariVest Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-8,618
Closed -$587K 849
2021
Q2
$587K Sell
8,618
-2,550
-23% -$166K 0.02% 408
2021
Q1
$774K Sell
11,168
-35,600
-76% -$2.74M 0.03% 330
2020
Q4
$3.59M Sell
46,768
-16,363
-26% -$1.23M 0.12% 143
2020
Q3
$4.72M Sell
63,131
-2,048
-3% -$137K 0.15% 113
2020
Q2
$4.1M Sell
65,179
-4,268
-6% -$235K 0.11% 131
2020
Q1
$2.92M Buy
69,447
+1,757
+3% +$80.6K 0.09% 157
2019
Q4
$3.08M Sell
67,690
-25,049
-27% -$1.18M 0.07% 194
2019
Q3
$4.24M Sell
92,739
-1,000
-1% -$56.2K 0.1% 180
2019
Q2
$5.5M Buy
93,739
+31,900
+52% +$1.65M 0.12% 151
2019
Q1
$2.77M Sell
61,839
-35,142
-36% -$1.61M 0.06% 274
2018
Q4
$3.78M Buy
96,981
+12,786
+15% +$502K 0.08% 205
2018
Q3
$3.87M Sell
84,195
-6,054
-7% -$245K 0.07% 216
2018
Q2
$3.93M Sell
90,249
-28,781
-24% -$1.24M 0.07% 233
2018
Q1
$4.7M Buy
119,030
+38,162
+47% +$1.48M 0.08% 198
2017
Q4
$2.75M Sell
80,868
-3,714
-4% -$106K 0.05% 292
2017
Q3
$2.16M Buy
+84,582
New +$1.94M 0.05% 277

Other funds holding ARNA

ClariVest Asset Management's ARNA Position: Q3 2021 in Review

ClariVest Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 8,618 shares — an estimated $587K sold.

ClariVest Asset Management first reported a position in ARNA in Q3 2017 and held it in 16 quarters. The position peaked at $5.5M in Q2 2019. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • ClariVest Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 8,618 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $587K.
  • ClariVest Asset Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 16 quarters.
  • ClariVest Asset Management's Arena Pharmaceuticals Inc position peaked at $5.5M in Q2 2019.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on ClariVest Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.